Research graph
References from Hepatic immune microenvironment dynamics in severe obesity and post-bariatric surgery: insights from immunohistochemical analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Obesity and severe obesity prevalence in adults: United States, August 2021-August 2023
10.15620/cdc/159281 · 2024 · External reference
Unresolved reference
External reference
Obesity: assessment and treatment across the care continuum
10.1080/07853890.2025.2521433 · 2025 · External reference
Long-term effectiveness, outcomes and complications of bariatric surgery
10.12998/wjcc.v11.i19.4504 · 2023 · External reference
Comparative analysis of bariatric surgery and non-surgical therapies: impact on obesity-related comorbidities
10.7759/cureus.69653 · 2024 · External reference
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: a systematic review and meta-analysis
10.3350/cmh.2023.0384 · 2024 · External reference
Laparoscopic sleeve gastrectomy in patients with severe obesity restores adaptive responses leading to nonalcoholic steatohepatitis
10.3390/ijms23147830 · 2022 · External reference
Impact of bariatric surgery and endoscopic therapies on liver health in metabolic dysfunction-associated steatotic liver disease: a review
10.3390/jcm14124012 · 2025 · External reference
Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): current knowledge of mechanisms
10.1097/hep.0000000000001417 · 2025 · External reference
The outcomes of Re-Redo bariatric surgery-results from multicenter Polish Revision Obesity Surgery Study (PROSS)
10.1038/s41598-024-52817-7 · 2024 · External reference
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
10.1016/s2468-1253(22)00317-x · 2023 · External reference
Active role of the immune system in metabolic dysfunction-associated steatotic liver disease
10.1093/gastro/goae089 · 2024 · External reference
Immune-mediated repair: a matter of plasticity
10.3389/fimmu.2017.00454 · 2017 · External reference
The "Domino effect" in MASLD: the inflammatory cascade of steatohepatitis
10.1002/eji.202149641 · 2024 · External reference
Roles of immune dysregulation in MASLD
10.1016/j.biopha.2023.116069 · 2024 · External reference
Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy
10.3389/fcell.2024.1444198 · 2024 · External reference
Understanding macrophage complexity in metabolic dysfunction-associated steatotic liver disease: transitioning from the M1/M2 paradigm to spatial dynamics
10.3390/livers4030033 · 2024 · External reference
Immunomodulation for tissue repair and regeneration
10.1007/s13770-023-00525-0 · 2023 · External reference
Metabolic reprogramming of immune cells in MASH
10.1097/hep.0000000000001371 · 2025 · External reference
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
10.1002/hep.20701 · 2005 · External reference
Digital pathology tailored for assessment of liver biopsies
10.3390/biomedicines13040846 · 2025 · External reference
Validation of whole-slide imaging in the primary diagnosis of liver biopsies in a university hospital
10.1016/j.dld.2017.07.002 · 2017 · External reference
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH
10.1016/j.jhep.2024.11.032 · 2025 · External reference
Unresolved reference
External reference
Macrophage polarization: an important role in inflammatory diseases
10.3389/fimmu.2024.1352946 · 2024 · External reference
Improvement in nonalcoholic fatty liver disease through bariatric surgery
10.1002/cld.1229 · 2022 · External reference
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
10.1016/s0140-6736(23)00634-7 · 2023 · External reference
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
10.1038/s41423-025-01307-5 · 2025 · External reference
The role of Kupffer cells and liver macrophages in the pathogenesis of metabolic dysfunction-associated steatotic liver disease
10.3390/biomedicines14010151 · 2026 · External reference
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
10.1016/j.cmet.2023.10.009 · 2023 · External reference
Neutrophil extracellular traps-triggered hepatocellular senescence exacerbates lipotoxicity in non-alcoholic steatohepatitis
10.1016/j.jare.2025.03.015 · 2026 · External reference
Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis
10.3389/fendo.2021.751802 · 2021 · External reference
Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: from intercellular signaling to clinical translation
10.4254/wjh.v17.i9.108259 · 2025 · External reference
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
10.1172/jci122258 · 2019 · External reference
miR-223 inhibits the polarization and recruitment of macrophages via NLRP3/IL-1β pathway to meliorate neuropathic pain
10.1155/2021/6674028 · 2021 · External reference
Over-expression of miR-223 induces M2 macrophage through glycolysis alteration and attenuates LPS-induced sepsis mouse model, the cell-based therapy in sepsis
10.1371/journal.pone.0236038 · 2020 · External reference
Neutrophils alleviate fibrosis in the CCl4-induced mouse chronic liver injury model
10.1002/hep4.1178 · 2018 · External reference
Immunoregulatory role of NK cells in tissue inflammation and regeneration
10.3389/fimmu.2017.00301 · 2017 · External reference
Mechanisms of innate immune cells in metabolic dysfunction-associated steatotic liver disease
10.3389/fimmu.2025.1599748 · 2025 · External reference
Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK/STAT pathway
10.1016/j.jcmgh.2021.08.019 · 2022 · External reference
Natural killer cells in liver disease
10.1002/hep.26115 · 2013 · External reference
NAP-2 secreted by human NK cells can stimulate mesenchymal stem/stromal cell recruitment
10.1016/j.stemcr.2016.02.012 · 2016 · External reference
Liver regeneration in chronic liver injuries: basic and clinical applications focusing on macrophages and natural killer cells
10.1016/j.jcmgh.2022.05.014 · 2022 · External reference
Unresolved reference
External reference
Macrophages in immunoregulation and therapeutics
10.1038/s41392-023-01452-1 · 2023 · External reference
Local administration of regulatory T cells promotes tissue healing
10.1038/s41467-024-51353-2 · 2024 · External reference
The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis
10.3389/fimmu.2025.1560578 · 2025 · External reference
Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma
10.1016/j.ebiom.2024.105031 · 2024 · External reference
The roles of T cells in the development of metabolic dysfunction-associated steatohepatitis
10.1111/imm.13943 · 2025 · External reference
Quantitative digital pathology reveals reversal of MASH-related liver damage following bariatric surgery
10.21203/rs.3.rs-8725050/v1 · 2026 · External reference
Analytical and clinical validation of AIM-NASH: a digital pathology tool for artificial intelligence-based measurement of nonalcoholic steatohepatitis histology
10.1101/2024.05.29.24308109 · 2024 · External reference
